From lipoproteins to chondrocytes: a brief summary of the European Medicines Agency's regulatory guidelines for advanced therapy medicinal products
Hum Gene Ther
.
2013 Jun;24(6):568-70.
doi: 10.1089/hum.2013.101.
Authors
Sadik H Kassim
1
,
Robert P T Somerville
Affiliation
1
Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. sadik.kassim@nih.gov
PMID:
23777464
PMCID:
PMC3689154
DOI:
10.1089/hum.2013.101
No abstract available
MeSH terms
Chondrocytes / cytology*
Drug Industry / legislation & jurisprudence
Europe
European Union
Guidelines as Topic*
Humans
Legislation, Drug*
Lipoproteins / metabolism*
Substances
Lipoproteins